{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:47:13Z","timestamp":1790729233956,"version":"4.1.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 64-year-old woman with metastatic breast cancer on follow-up had suspicious recurrent brain metastases. She underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT, <jats:sup>18<\/jats:sup>F-PSMA 1007 brain PET\/CT, and brain MRI. <jats:sup>18<\/jats:sup>F-PSMA 1007 showed intense tracer localization in the suspected recurrent brain metastasis in right parietal lobe and also picked up 2 more metastatic brain lesions, which had concurrent findings of metastasis in subsequent MRI. Our case highlights the feasibility of <jats:sup>18<\/jats:sup>F-PSMA 1007 PET\/CT imaging of brain metastases from nonprostate cancers. It may be used as surrogate imaging tracer for potential theranostic application using alpha or beta emitters considering its similarity to PSMA-617.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002821","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:08:55Z","timestamp":1573067335000},"page":"e77-e79","source":"Crossref","is-referenced-by-count":18,"title":["18F-PSMA 1007 Uptake in Brain Metastases From Breast Cancer"],"prefix":"10.1097","volume":"45","author":[{"given":"Fahad","family":"Marafi","sequence":"first","affiliation":[{"name":"Jaber Alahmad Centre for Molecular Imaging, Shuwaikh, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sasikumar","sequence":"additional","affiliation":[{"name":"St Gregorios International Cancer Care Centre, Parumala, Pathanmthitta, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Alfeeli","sequence":"additional","affiliation":[{"name":"Jaber Alahmad Centre for Molecular Imaging, Shuwaikh, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Fathallah","sequence":"additional","affiliation":[{"name":"Kuwait Cancer Control Centre, Shuwaikh, Kuwait."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00259-017-3854-6","article-title":"Simultaneous whole-body (18)F-PSMA-1007-PET\/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2967\/jnumed.117.196329","article-title":"Biochemical recurrence of prostate cancer: initial results with [(18)F]PSMA-1007 PET\/CT","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2967\/jnumed.116.189233","article-title":"Intraindividual comparison of (18)F-PSMA-1007 PET\/CT, multiparametric MRI, and radical prostatectomy specimens in patients with primary prostate cancer: a retrospective, proof-of-concept study","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1097\/RLU.0000000000002543","article-title":"Detection of local relapse of prostate cancer with 18F-PSMA-1007","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib6-20230925","first-page":"6","article-title":"More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET\/CT","volume":"22","year":"2019","journal-title":"Hell J Nucl Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00259-016-3447-9","article-title":"(18)F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/RLU.0000000000001451","article-title":"Diagnostic value of 68Ga PSMA-11 PET\/CT imaging of brain tumors-preliminary analysis","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1097\/RLU.0000000000002175","article-title":"Utility of 68Ga-PSMA-11 PET\/CT in imaging of glioma\u2014a pilot study","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/RLU.0000000000000709","article-title":"Detection of brain metastasis with 68Ga-labeled PSMA ligand PET\/CT: a novel radiotracer for imaging of prostate carcinoma","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/RLU.0000000000001526","article-title":"Cerebellar metastases from prostate cancer on 68Ga-PSMA PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10585-018-9878-x","article-title":"Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases","volume":"34","year":"2017","journal-title":"Clin Exp Metastasis"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00259-016-3563-6","article-title":"(68)Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:06:20Z","timestamp":1695621980000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002821","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,31]]}}}